Kainos Medicine Inc (284620) - Total Liabilities

Latest as of June 2025: ₩4.18 Billion KRW ≈ $2.84 Million USD

Based on the latest financial reports, Kainos Medicine Inc (284620) has total liabilities worth ₩4.18 Billion KRW (≈ $2.84 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Kainos Medicine Inc (284620) cash conversion ratio to assess how effectively this company generates cash.

Kainos Medicine Inc - Total Liabilities Trend (2017–2024)

This chart illustrates how Kainos Medicine Inc's total liabilities have evolved over time, based on quarterly financial data. Check 284620 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Kainos Medicine Inc Competitors by Total Liabilities

The table below lists competitors of Kainos Medicine Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Times Guaranty Limited NSE:TIMESGTY	India	Rs1.67 Million
Kyobo 3 SPAC KQ:208710	Korea	₩45.30 Billion
Avenira Ltd AU:AEV	Australia	AU$5.47 Million
Sin-Kung Logistics Berhad KLSE:0305	Malaysia	RM74.06 Million
Netgem SA PA:ALNTG	France	€13.72 Million
DRC Systems India Limited NSE:DRCSYSTEMS	India	Rs406.32 Million
TT Vision Holdings Berhad KLSE:0272	Malaysia	RM30.83 Million
Orion Digital Corp. TO:ORIO	Canada	CA$101.48 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Kainos Medicine Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 284620 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kainos Medicine Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kainos Medicine Inc (2017–2024)

The table below shows the annual total liabilities of Kainos Medicine Inc from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩8.95 Billion ≈ $6.07 Million	-3.03%
2023-12-31	₩9.23 Billion ≈ $6.26 Million	-28.27%
2022-12-31	₩12.87 Billion ≈ $8.72 Million	-56.88%
2021-12-31	₩29.85 Billion ≈ $20.23 Million	+33.12%
2020-12-31	₩22.43 Billion ≈ $15.20 Million	+2739.13%
2019-12-31	₩789.89 Million ≈ $535.30K	+2.31%
2018-12-31	₩772.06 Million ≈ $523.21K	+4.31%
2017-12-31	₩740.19 Million ≈ $501.62K	--

About Kainos Medicine Inc

KQ:284620 Korea Biotechnology

Market Cap

$24.10 Million

₩35.56 Billion KRW

Market Cap Rank

#24437 Global

#1800 in Korea

Share Price

₩1087.00

Change (1 day)

-8.81%

52-Week Range

₩977.00 - ₩1270.00

All Time High

₩28151.21